The School of Dental Sciences, Sharda University has signed an MOU with Oncocur India Pvt. Ltd., a nutri-pharmaceutical company based out of Pune for conducting research on Brecan Plus, a nano-curcumin supplement that helps in the prevention of progression of lesions, which leads to oral cancer.
As part of the research, the medical solution will be tried clinically on patients with lesions. The University has received a grant of INR 6,00,000 from Oncocur India Pvt. Ltd. for conducting researches and trials on three potentially cancerous lesions, and one non-cancerous debilitating lesion of the mouth.
Speaking on the collaboration Dr. Deepak Bhargava, Professor and Head, Department of Oral Pathology, Sharda University said to the leading media agency “The research will aid better, faster and effective cancer and pre-cancer diagnosis, care, and management. As part of the studies conducted by the department on oral pre-cancer, the research and the grant is a great step towards delivering innovative treatment to curb cancer in the preliminary stages. The research aims to aid the chemoprevention of the lesions over multiple patients in various formats and levels of evidence. The lesions covered within the scope of the research include- Oral Sub Mucous Fibrosis (Limitation in mouth opening), Lichen Planus (Stress-induced white patches in the mouth), Leukoplakia (Tobacco induced white patches in the mouth) and Recurrent Aphthous Ulcers (Ulcers that are persistent despite treatment).”
Dr Vijay Kanuru, Founder CEO, ONCOCUR INDIA Pvt Ltd said to lead media agency “We are proud to announce our collaboration with the Department of Oral Pathology, School of Dental Sciences – Sharda University towards research on potential oral cancerous lesions. The current treatment for these lesions consists of medications that have serious known side effects, whereas the proposed treatment uses the isolated principle-active component (Nano-Curcumin) derived out of turmeric to resolve the lesions without any side effects at the preliminary stages.”